Hudson Pharma is a pharmaceutical company with the slogan "Safety & Innovation." Founded in 2010, their mission revolves around identifying molecules that cater to unmet medical needs globally. Operating from a plant in Karachi, Pakistan, the company specializes in the production of injectables, oral liquids, and respules using innovative blow fill seal (BFS) processes. They also have separate manufacturing lines for ophthalmological and dermatological products. Hudson Pharma's focus areas encompass respiratory products, vitamins, dermatological products, diluting agents, anti-inflammatories, anesthetics, anti-infectives, anti-nauseants, anti-emetics, anti-ulcers, NSAIDs, and ophthalmics. They engage in developing, contract manufacturing, and marketing branded generic and specialty drugs. The company has immense potential in tapping into developing markets by introducing efficacious molecules with improved safety and manufacturing processes. While details about their headquarters and recent investments are not available, their unique approach to pharmaceutical manufacturing positions Hudson Pharma as a promising player in the industry, worth monitoring for investment opportunities.
There is no investment information
No recent news or press coverage available for Hudson Pharma.